Rockville, MD, United States of America

Xin Yao

This inventor holds 11 USPTO granted patents and 14 published patent applications and 3 EPO patents. Top assignees: Abelzeta Inc., Cellular Biomedicine Group Hk Limited, Cellular Biomedicine Group (Shanghai) Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Yao. Retrieved from https://idiyas.com/inventor/xin-yao-3ccs49e8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 36.4

 

Average Co-Inventor Count = 6.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations of Inventor Xin Yao

Introduction

Xin Yao is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of chimeric antigen receptors. With a total of 11 patents, his work focuses on innovative solutions for treating autoimmune disorders and cancer.

Latest Patents

One of Xin Yao's latest patents is titled "Bispecific chimeric antigen receptors targeting CD20 and BCMA." This invention provides a novel approach by combining an scFv targeting CD20 and an scFv targeting BCMA, along with a hinge region, a transmembrane domain, a co-stimulatory region, and a cytoplasmic signaling domain. These chimeric antigen receptors can be utilized in the treatment of autoimmune disorders or cancer. Another significant patent is "Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof." This invention includes a combined chimeric antigen receptor that targets both CD19 and CD20, demonstrating high efficacy in killing tumor cells. The invention also encompasses a nucleic acid molecule encoding the chimeric antigen receptor and a corresponding expression vector, along with applications for CAR-T cells.

Career Highlights

Xin Yao has worked with prominent organizations such as Abelzeta Inc. and the National Institutes of Health, which is a component of the US Department of Health & Human Services. His experience in these institutions has contributed to his expertise in the field of chimeric antigen receptors and their applications in medicine.

Collaborations

Xin Yao has collaborated with notable colleagues, including Yihong Yao and Jiaqi Huang. Their combined efforts have further advanced the research and development of innovative therapies in the biomedical sector.

Conclusion

Xin Yao's contributions to the field of biomedical engineering through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in the treatment of serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…